Introduction 57
Protein glycation includes an initial formation of Shiff's base, followed by intermolecular 58 rearrangement and conversion into Amadori products. They undergo further processing to form a 59 heterogeneous group of protein-bound moieties, such as cross-linking fluorescent (e.g., 60 pentosidine) and non-fluorescent adducts (e.g., N ε -(carboxymethyl)lysine) (CML), N ε -61 (carboxyethyl)lysine (CEL)) called advanced glycation end products (AGEs). 1 Pathways of AGE 62 formation involve glucose autoxidation through the generation of α-oxoaldehydes, such as 63 methylglyoxal (MGO), 3-deoxyglucosone and glyoxal. MGO is a major precursor of AGEs, 64 especially CEL, which is capable of binding and modifying a number of proteins (glycoxidation 65 reaction), including bovine serum albumin (BSA), RNase A, collagen, lysozyme and lens 66 crystallins. 2,3 Protein glycation is known to be involved in the pathogenesis of several age-related 67 disorders like diabetes, atherosclerosis, end-stage renal and neurodegenerative diseases. 4 68
Inhibitors of AGEs formation might follow several mechanisms, such as aldose reductase, 69 antioxidant activity, reactive dicarbonyl trapping, sugar autoxidation inhibition and amino group 70 binding. 5 The inhibition of AGE formation by synthetic aminoguanidine (AG) has been widely 71 documented. However, as AG treatment in type 1 diabetics has caused serious complications, the 72 search for natural AGE inhibitors is currently a challenge. 6 73
Coffee and yerba mate are considered natural sources of abundant phenolic compounds that can 74 inhibit the formation of AGEs. 7, 8 The most representative phenolic acids in these foods are 75 chlorogenic acids (CGA), which commonly occur as 5-O-caffeoylquinic acid (5-CQA) or 3-O-76 caffeoylquinic acid (3-CQA). 9,10 The antiglycation activity of CGA has been associated to its 77 antioxidant and chelating characters, as well as to its ability to trap reactive dicarbonyl 78 compounds. 8, 11 This study aimed to obtain a better understanding of the antiglycoxidative 79 mechanism of action of CGA which is partly unknown. In vitro studies mimicking physiological 80 conditions were performed to achieve this goal. 81
Materials and methods 82
buffered saline (PBS), 3-O-caffeoylquinic acid (CGA), sodium azide, ortho-phthaldialdehyde 85 (OPA), N α -acetyl-L-lysine, Folin-Ciocalteau, 3.3′, 5.5′-Tetramethylbenzidine (TMB) were from 86
Sigma-Aldrich (St. Louis, USA). Other chemicals and their suppliers were as follows: β-87 mercaptoethanol (Merck, Hohenbrunn, Germany), methylglyoxal solution (MGO) and 2.2'-88 azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt (ABTS) (Fluka, Buchs, 89 Switzerland) and Bradford reagent for protein assay (Bio-Rad, München, Germany). The 90
Amicon ® Ultra-0.5 ml centrifugal filter unit fitted with an Ultracel ® -30K regenerated cellulose 91 
HPLC analysis 98
Standard CGA before and after incubation at 37 ºC for 24 h were compared to assess the chemical 99 stability of the compound under experimental conditions by reversed phase (RP) HPLC. A 100 modular chromatographer HP 1100 (Agilent Technologies, Paolo Alto, CA, USA) equipped with 101 a multi-waves UV-Vis detector was used to analyse samples. The stationary phase was a 250 x 102 2.1 mm i.d. C18 RP column, particle diameter 4 μm (Jupiter Phenomenex, Torrance, CA, USA). 103
Column temperature was maintained at 37 °C during the HPLC analyses. Separations were carried 104 out at a constant flow rate of 0.2 mL min -1 applying a 5-60% linear gradient of solvent B 105 (acetonitrile/ 0.1% trifluoroacetic acid, TFA) over 60 min, after 5 min of isocratic elution at 5% 106 solvent B. Solvent A was 0.1% TFA in HPLC-grade water. For each run, 2.5 μg standard or were recorded using a diode array detector. 110
MALDI-TOF-MS analysis 111
Mass spectra of CGA freshly prepared and incubated at 37 ºC for 24 h were acquired on a 112 Voyager DE-Pro spectrometer (PerSeptive BioSystems, Framingham, Massachusetts) equipped 113 with a N2 laser (λ= 337 nm) operating in both positive and negative reflector ion modes. The 114 matrix was 2.5-hydroxybenzoic acid (DHB) 10 mg mL -1 in 50% acetonitrile. In the positive ion 115 mode, the matrix solution also contained 0.1% TFA. Spectra were acquired using Delay 116
Extraction technology at an accelerating voltage of 20 kV, exploring the m/z 150−1200 range. 117
Matrix ion signals were excluded by separately acquiring positive and negative spectra of DHB. 118
The mass range was externally calibrated with a mixture of standard polyphenols (Sigma, Milan, 119
Italy). Spectra were elaborated with Data Explorer 4.0. The formation of total AGEs-BSA was measured by an indirect ELISA assay in samples 150 incubated for 72 h. A high affinity protein 96-well microplate was coated overnight (4° C) with 151 100 µL of protein samples in 0.01 M phosphate buffer (pH 7.4) (5 µg mL -1 ). Unbound proteins 152 were washed out with buffer PBS-T (PBS 0.01 M; Tween 0.05%), the wells were blocked with 153 gelatin 0.5% for 1 h at room temperature, then washed out with PBS-T, and the primary antibody 154 Samples were analysed in triplicate. 167
Structural changes of proteins 168
Prior to analysis, the protein fraction of samples incubated at 37 ºC for 72 h was isolated by 169 ultrafiltration. Samples (0.4 mL) were placed in the sample reservoir of an Amicon ® Ultra-0.5 mL 170 centrifugal filter unit fitted with an Ultracel ® -30K regenerated cellulose membrane (30 kDa cut-171 off) (Millipore Ltd., Ireland) and centrifuged at 14000 g for 40 min at room temperature. The 172 concentrated samples were recovered and diluted in PBS (0.4 mL). Protein concentration was 173 determined by the Bradford micromethod. The isolated protein fraction was used for structural and 174 functional characterisation. 175
UV-Vis spectra 176
A Biotek microplate UV-Vis spectrophotometer equipped with UV KC junior software (Biotek) 177 was used. The spectrum of fractionated samples was measured at 200-790 nm using a quartz 96-178 well microplate. 179
Total phenolic compounds 180
Total phenolic content (TPC) of the isolated fraction incubated for 72 h was determined using the 181
Folin-Ciocalteu method as described by Singleton et al. 13 adapted to a microplate reader. The 182 reduction reaction was carried out in 210 µL total volume in 96-well microplates (No. 82.1581).
Ciocalteu reagent (diluted 1:14, v/v) in Milli-Q water. After exactly 3 minutes, 4 mL of 75 g L -1 185 sodium carbonate solution and 6 mL of water were mixed, and 50 µL of this mixture was added 186 to each well. Absorbance at 750 nm was recorded using a microplate reader BioTek 187
PowerWave™ XS. Calibration curves were constructed using standard solutions of CGA (0.1-1 188 mg L -1 ), and results were expressed as µg CGA mL -1 . 
Statistical analysis 208
Data were expressed as mean ± standard deviation (SD). Analysis of Variance (more than 2 209 groups), one-way and two-way ANOVA followed by Bonferroni test, were applied to determine 210 differences between means. Differences were considered to be significant at p < 0.05. 211
Relationships between the analysed parameters were evaluated by computing Pearson linear 212 correlation coefficients setting the level of significance at p < 0.001. The MALDI-TOF-MS (Fig. 1b) The availability of free amino groups was obtained by OPA assay (Fig. 2) . Incubation of BSA 228 alone at 37 ˚C for 192 h did not significantly affect (p > 0.001) the availability of free amino 229 groups, indicating the absence of inter-protein cross-linking events. Incubation in the presence of 230 MGO produced a significant decrease (p < 0.001) in BSA free amino groups during the incubation 231 period, suggesting that the glycoxidation reaction occurred. Interestingly, the addition of CGA to 232 the glycoxidation mixture (BSA+MGO) also caused a significant decrease (p < 0.001) in available 233 free amino groups throughout the whole incubation period. Available free amino groups also 234 decreased when BSA was incubated with CGA alone compared to the protein control and did not significantly differ (p > 0.001) from those of the inhibition model composed of BSA, MGO and 236 CGA. 237 
Structural changes of protein 257
Since significant AGE formation was observed after 72 h of glycoxidation reaction ( Fig. 3 and  258 Table 2), those samples were selected for further characterisation. As shown in Fig. 5a , fresh and 259 incubated (37 ˚C for 72 h) BSA solutions exhibited identical UV-Vis spectra, suggesting that no structural modifications of proteins occurred following heating. Furthermore, the glycoxidation 261 reaction BSA+MGO did not alter the UV-Vis spectrum compared to fresh BSA. In contrast, the 262 protein fraction isolated from the glycoxidation mixture with CGA showed a very different 263 spectrum than that found for the control (BSA) and was very similar to the spectrum of BSA 264 incubated with CGA. 265
Total phenolic content of the samples incubated at pH 7.4, 37 ºC for 72 h is shown in Fig. 5b . As 266 expected, significant levels (p < 0.05) of phenolic compounds were detected in the protein 267 fractions isolated from the CGA model systems, namely BSA + CGA and BSA + MGO + CGA. 268
MALDI-TOF-MS analysis was performed to confirm the formation of covalent bindings of CGA 269
to the protein backbone at 72 h (Fig. 6 ). In the spectra corresponding to BSA incubated with 270 MGO, the characteristic peak of BSA was clearly visible with variable mass increases (Fig. 6b) . 271
Greater mass shifts were observed when BSA was incubated with CGA either in the absence (Fig.  272 6c) or presence of MGO (Fig. 6d ). The mass data suggested that, BSA binds several molecules of 273 CGA and its derivatives in addition to the MGO in these samples, forming a heterogeneous 274 mixture of protein conjugates as reflected by the broadening of BSA peaks ( Fig. 6c and 6d) . 275
Changes of protein function 276
The antioxidant capacity of the isolated protein fractions obtained from samples incubated at 37 277 ºC for 72 h is shown in Fig. 7 . The reaction with MGO did not modify the antioxidant capacity of 278
BSA. The addition of CGA to reaction mixtures caused the formation of compounds (MW > 30 279 kDa) which had antioxidant capacity values of 303.07 and 309.89 μg eq-CGA mL -1 for model 280 system composed of BSA+MGO+CGA and BSA+CGA, respectively. 281
Correlation between parameters 282
A significant negative correlation (r=-0.754, p < 0.001) between data corresponding to free amino 283 groups and antioxidant capacity was observed for samples incubated at 37 ºC for 72h. A significant negative correlation (r=-0.689, p < 0.001) was also found between free amino groups 285 and total phenolic content. 286
Discussion 287
In this work we observed that structural changes in CGA produced in vitro under mimicked 288 physiological conditions may contribute to the antiglycoxidative properties of this compound. CGA to inhibit in vitro BSA glycation induced by fructose and glucose and the formation of AGE 329 crosslinking from collagen. 11 We have recently reported that MGO is effectively trapped by CGA 330
with an IC50 of 0.14 mg mL -1 . 30 In addition to this mechanism, we propose for the first time a 331 relationship between the high binding capacity of CGA to BSA and its antiglycoxidative 332 mechanism of action. The covalent interactions suggest MGO and GCA are competing for reactive 333 protein sites (free amine group). This effect prevents MGO from binding to BSA resulting in an 334 effective decrease in AGE formation.
Coffee is the major source of CGA on the worldwide diet. CGA from coffee has shown a high 336 bioavailability in humans. 31 Previous studies suggest that consumption of coffee acutely increases 337 the concentrations of phenolic compounds in LDL cholesterol particles and platelets, increases ex 338 vivo resistance to LDL oxidation, and reduces platelet aggregation in healthy volunteers. 32,33 339
These results support formation of antioxidant polyphenol-protein complexes in vivo and ex vivo 340 with health promoting properties. Formation of polyphenol-protein complexes in vivo is feasible 341 and it may be associated to a reduction of risk of diabetes complications such as cardiovascular 342
disease. 343
In summary, the covalent conjugation of CGA and its derivatives (isomers and quinones) to side-344 chains of protein lysine residues reduces the formation of potentially harmful compounds, also 345 called AGEs, and promotes the generation of antioxidant structures, which may be beneficial for 346 human health. 
